Literature DB >> 29417424

KIAA2022-related disorders can cause Jeavons (eyelid myoclonia with absence) syndrome.

Debopam Samanta1, Erin Willis2.   

Abstract

Entities:  

Year:  2018        PMID: 29417424     DOI: 10.1007/s13760-018-0887-y

Source DB:  PubMed          Journal:  Acta Neurol Belg        ISSN: 0300-9009            Impact factor:   2.396


× No keyword cloud information.
  5 in total

1.  RLIM Is a Candidate Dosage-Sensitive Gene for Individuals with Varying Duplications of Xq13, Intellectual Disability, and Distinct Facial Features.

Authors:  Elizabeth E Palmer; Renee Carroll; Marie Shaw; Raman Kumar; Andre E Minoche; Melanie Leffler; Lucinda Murray; Rebecca Macintosh; Dale Wright; Chris Troedson; Fiona McKenzie; Sharron Townshend; Michelle Ward; Urwah Nawaz; Anja Ravine; Cassandra K Runke; Erik C Thorland; Marybeth Hummel; Nicola Foulds; Olivier Pichon; Bertrand Isidor; Cédric Le Caignec; Bénédicte Demeer; Joris Andrieux; Salam Hadah Albarazi; Ann Bye; Rani Sachdev; Edwin P Kirk; Mark J Cowley; Mike Field; Jozef Gecz
Journal:  Am J Hum Genet       Date:  2020-11-06       Impact factor: 11.025

2.  Clonazepam as an Effective Treatment for Epilepsy in a Female Patient with NEXMIF Mutation: Case Report.

Authors:  Masashi Ogasawara; Eiji Nakagawa; Eri Takeshita; Kohei Hamanaka; Satoko Miyatake; Naomichi Matsumoto; Masayuki Sasaki
Journal:  Mol Syndromol       Date:  2020-09-01

3.  Torpedo Maculopathy Associated with NEXMIF Mutation.

Authors:  Tuğba Alarcon-Martinez; Ayesha Khan; Kenneth A Myers
Journal:  Mol Syndromol       Date:  2019-03-15

4.  Case Report: A Case of Eyelid Myoclonic Status With Tonic-Clonic Seizure and Literature Review.

Authors:  Yujun Yuan; Fenghua Yang; Liang Huo; Yuying Fan; Xueyan Liu; Qiong Wu; Hua Wang
Journal:  Front Pediatr       Date:  2021-04-22       Impact factor: 3.418

Review 5.  Candidate Genes for Eyelid Myoclonia with Absences, Review of the Literature.

Authors:  Sonia Mayo; Irene Gómez-Manjón; Fco Javier Fernández-Martínez; Ana Camacho; Francisco Martínez; Julián Benito-León
Journal:  Int J Mol Sci       Date:  2021-05-25       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.